Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charles Farkas currently holds 14,859 shares of CONMED CORP (CNMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles Farkas has been a net buyer of CNMD stock. They have purchased $138.6K and sold $107.1K worth of shares.
Charles Farkas's most recent insider trade was on Sep 12, 2025, when they sold 897 shares at $53.51 per share.
Charles Farkas serves as Executive at CONMED CORP (CNMD). They have executed 34 insider transactions totaling $245.7K over their tenure at the company.
Charles Farkas holds the position of Executive at CONMED CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Charles Farkas has shown a buying trading pattern, with $138.6K in total purchases and $107.1K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Charles Farkas was on Sep 12, 2025, when they sold $59.1K worth of CNMD shares. This transaction involved 1,103 shares at $53.54 per share.
Charles Farkas currently owns 14,859 shares of CONMED CORP (CNMD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charles Farkas's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charles Farkas has 34 Form 4 filings on record as an insider at CONMED CORP.
Set alerts for Charles Farkas and 40,000+ other insiders.